MediWound Ltd.

About MediWound Ltd.

MediWound is a biotechnology company focused on redefining wound care through next-generation enzymatic treatments. Their solutions selectively remove eschar tissue while preserving healthy tissue, aiming to accelerate healing, improve outcomes, and reduce healthcare costs for burns and chronic wounds. As a fully integrated company, MediWound delivers transformative therapies globally, addressing unmet medical needs and improving patients' lives.

Products & Services

NexoBrid(r):A treatment for severe burns, indicated for eschar removal in deep partial-thickness and full-thickness thermal burns. Classified as an orphan biological drug, it targets hospitalized patients and is approved in the U.S., EU, and Japan.

EscharEx(r):A next-generation enzymatic therapy candidate for wound care, indicated for debridement of chronic and hard-to-heal wounds. Classified as a biological drug, it targets patients in all wound care settings, with Phase 3 trials ongoing for venous leg ulcers (VLU) and planned trials for diabetic foot ulcers (DFU).

Specialties

Enzymatic Therapeutics Wound Care Burn Treatment Chronic Wound Debridement

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: EIC Accelerator Funding (Blended: Grant and Equity) T: - FT: EIC Accelerator Funding (Blended: Grant and Equity)	A: 16250000 MR: - FA: €16.25 million FAN: 16250000	D: 2024-07-16 FD: 2024-07-16	1 investors
2	RT: PIPE T: - FT: PIPE	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2024-07-15 FD: 2024-07-15	1 investors
3	RT: Grant T: - FT: Grant	A: 6700000 MR: - FA: $6.7 million FAN: 6700000	D: 2023-12-28 FD: 2023-12-28	1 investors
4	RT: Government Grant T: - FT: Government Grant	A: 6500000 MR: - FA: $6.5 million FAN: 6500000	D: 2023-09-26 FD: 2023-09-26	1 investors
5	RT: Grant T: - FT: Grant	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2023-05-09 FD: 2023-05-09	1 investors
6	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 27500000 MR: - FA: 27.5 million FAN: 27500000	D: 2023-02-07 FD: 2023-02-07	1 investors
7	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 27500000 MR: - FA: 27.5 million FAN: 27500000	D: 2023-02-03 FD: 2023-02-03	-

EIC Accelerator Funding (Blended: Grant and Equity) Latest

2024-07-16

$16.2M

1 investor (Pro only)

PIPE 2024-07-15

$25.0M

Grant 2023-12-28

$6.7M

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

O

Ofer Gonen

Chief Executive Officer

LinkedIn (Pro only)

E

Ety Klinger

Chief Research and Development Officer

LinkedIn (Pro only)

S

Shmulik Hess

Chief Operating and Commercial Officer

LinkedIn (Pro only)

H

Hani Luxenburg

Chief Financial Officer

R

Robert J. Snyder

Chief Medical Officer

Y

Yaron Meyer

EVP, General Counsel & Corporate Secretary

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

MediWound Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

About MediWound Ltd.

Products & Services

Specialties

Funding History

Growth Metrics

Team & Leadership

Recent News

MediWound Ltd. Announces New Product Launch

Leadership Team Expands with Industry Veteran

Company Recognized as Industry Leader

Key Competitors

Competitor Alpha

Competitor Beta

Competitor Gamma

Competitor Delta

Company Details

Technology Stack